Present Position:

Medical Doctor, Senior Assistant Professor, Department of Otorhinolaryngology, Jikei University School of Medicine,

Researcher, Department of Anatomy, Jikei University School of Medicine

Researcher, Central Institute for Experimental Animals Humanized Model Laboratory

Academic social activities:

The Oto-Rhino-Laryngological Society of Japan (Regular member)

The Tokyo Branch of the Oto-Rhino-Laryngological Society of Japan (Councilor)

Japan Otological Society (Councilor)

The Japan Society of Histochemistry and Cytochemistry (Councilor)

Japanese Association of Anatomists (Regular member)

The Japanese Society for Clinical Molecular Morphology (Regular member)

Auris Nasus Larynx (reviewer)

Oto-Rhino-Laryngological, Tokyo (Editorial Board Member)

The International Conference on Cholesteatoma and Ear Surgery(International Scientific Committee)

The International Society for Otitis Media (Regular member)

The American Society for Investigative Pathology (Regular member)

Naotaro Akiyama, MD, PhD, is a Senior Assistant Professor in the Department of Otorhinolaryngology at Jikei University School of Medicine, Tokyo, Japan. He is a board-certified otolaryngologist with expertise in otology and middle ear diseases. His research focuses on the molecular and epigenetic mechanisms underlying middle ear cholesteatoma and external auditory canal carcinoma. He has published extensively in leading otolaryngology and pathology journals. He is an active member of several national and international scientific societies.

Dr. Park is the past division chief of pediatric otolaryngology at the University of Utah, the current endowed presidential chair for research and director of the multidisciplinary pediatric hearing center. He has had a long-standing interest in pediatric hearing loss. His team has implemented a state-wide expanded targeted early cytomegalovirus (CMV) screening for newborns, a multi-disciplinary congenital CMV clinic for children diagnosed with this condition, the first clinically validated dry blood spot and saliva PCR assays and a murine model to study CMV mediated hearing loss.

Dr. Liu is a pediatric otolaryngologist with a clinical focus on children with hearing loss, chronic ear diseases, eustachian tube dysfunction, and microtia and aural atresia repair. I am currently the Director of the Microtia and Atresia Clinic at Texas Children’s Hospital (TCH) and the co-surgical lead for the Eustachian Tube Dysfunction program. I have led and actively participated in several clinical outcomes and human research projects. My goal is to continually improve and develop specific diagnostic and therapeutic interventions for pediatric ear disorders.